TSE:AEZ

43844 (AEZ.TO) Stock Forecast, Price & News

Add

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume1,000 shs

Average Volume12,504 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The Company's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange TSE

Industry N/A

Sub-IndustryN/A

SectorN/A

Current SymbolTSE:AEZ

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.aezsinc.com

Phone+1-843-9003223

EmployeesN/A

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares11,671,000

Market CapN/A

Next Earnings Date3/29/2021 (Estimated)

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.56 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for 43844 (AEZ.TO).

2.8 Community Rank

Outperform Votes
43844 (AEZ.TO) has received 102 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
43844 (AEZ.TO) has received 83 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
43844 (AEZ.TO) has received 55.14% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about 43844 (AEZ.TO) and other stocks. Vote “Outperform” if you believe AEZ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AEZ will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
43844 (AEZ.TO) does not currently pay a dividend.
Dividend Growth
43844 (AEZ.TO) does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, 43844 (AEZ.TO) insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

30 days | 90 days | 365 days | Advanced Chart

Receive AEZ News and Ratings via Email

Sign-up to receive the latest news and ratings for AEZ and its competitors with MarketBeat's FREE daily newsletter.

43844 (AEZ.TO) (TSE:AEZ) Frequently Asked Questions

What stocks does MarketBeat like better than 43844 (AEZ.TO)?

Wall Street analysts have given 43844 (AEZ.TO) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but 43844 (AEZ.TO) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is 43844 (AEZ.TO)'s next earnings date?

43844 (AEZ.TO) is scheduled to release its next quarterly earnings announcement on Monday, March 29th 2021.
View our earnings forecast for 43844 (AEZ.TO).

Who are 43844 (AEZ.TO)'s key executives?

43844 (AEZ.TO)'s management team includes the following people:

Carolyn Egbert, Independent Chairman of the Board
Michael Ward, President, Chief Executive Officer, Director
James Clavijo, Chief Financial Officer (Age 52)
Richard Sachse M.D. Ph.D., Senior Vice President, Chief Scientific Officer, Chief Medical Officer
Jude Dinges, Chief Commercial Officer, Senior Vice President (Age 58)
Eckhard G. Gunther Ph.D., Vice President - Alliance Management
Michael Teifel, Vice President - Non-Clinical Sciences
John W. Sharkey Ph.D., Business Development Consultant (Age 60)
Philip Allen Theodore, Corporate Secretary (Age 64)
David A. Dodd, Director (Age 65)

What other stocks do shareholders of 43844 (AEZ.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 43844 (AEZ.TO) investors own include Aeterna Zentaris (AEZS), AltaGas (ALA), Dollar General (DG), Bristol-Myers Squibb (BMY), Corus Entertainment (CJR.B), Costco Wholesale (COST), Cisco Systems (CSCO), Morgan Stanley (MS), Target (TGT) and Tandem Diabetes Care (TNDM).

What is 43844 (AEZ.TO)'s stock symbol?

43844 (AEZ.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "AEZ."

How do I buy shares of 43844 (AEZ.TO)?

Shares of AEZ and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

How much money does 43844 (AEZ.TO) make?

43844 (AEZ.TO) has a market capitalization of C$0.00.

What is 43844 (AEZ.TO)'s official website?

The official website for 43844 (AEZ.TO) is www.aezsinc.com.

Where are 43844 (AEZ.TO)'s headquarters?

43844 (AEZ.TO) is headquartered at 315 Sigma Dr Ste 302D, SUMMERVILLE, SC 29486-7790, United States.

How can I contact 43844 (AEZ.TO)?

43844 (AEZ.TO)'s mailing address is 315 Sigma Dr Ste 302D, SUMMERVILLE, SC 29486-7790, United States. The biopharmaceutical company can be reached via phone at +1-843-9003223.

This page was last updated on 3/4/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here